Before considering the safety of GLP-1 drugs for people with hemophilia, it helps to understand the link between hemophilia, diabetes, and obesity
We need to acknowledge the complexity of the disease [of obesity] and the complexity of well-managed care, and that the relationship between the two is key. Tracy Zvenyach GLP-1s Are Safe Although GLP-1s have only recently become well-known to the public, they have been used to treat diabetes for 20 years, and there are many studies that show that these drugs are both safe and effective
Importantly, GCGR agonist is also associated with increased energy expenditure, a key factor in weight management and metabolic health
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
What Patients Need to Know About the GLP-1 FDA Policy Changes Medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) belong to a class called glucagon-like peptide-1 (GLP-1) receptor agonists
For patients with type 2 diabetes or metabolic syndrome, these metabolic benefits may justify continued treatment even after weight loss goals are met